Calliditas Therapeutics to Attend Investor Conferences in March

Rhea-AI Summary

Calliditas Therapeutics AB (Nasdaq: CALT) announces CEO's participation in March 2024 conferences, including Carnegie Healthcare Seminar and Jefferies Biotech Summit. For more details, contact Head of IR & Sustainability, Åsa Hillsten.

STOCKHOLM, March 1, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) and (Nasdaq Stockholm: CALTX) ("Calliditas"), a commercial biopharma company focused on rare diseases today announced that Renee Aguiar-Lucander, CEO of Calliditas will participate in the following March 2024 conferences.  

Carnegie Healthcare Seminar, Wednesday, March 6, 2024.  Fireside chat will be held at 10:20 - 10:50 am CET and one-on-one meetings will be available. 

Jefferies Biotech on the Bay Summit, Wednesday, March 13, 2024 in Miami, FL, one-on-one meetings will be available. 

Leerink Partners Global Biopharma Conference on March 12, 2024 in Miami, FL.

For further information, please contact:

Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com

The information was sent for publication, through the agency of the contact person set out above, on March 1, 2024, at 13:00 CET.

The following files are available for download:

https://mb.cision.com/Main/16574/3939155/2640916.pdf

PM_March Events_ENG

View original content:https://www.prnewswire.com/news-releases/calliditas-therapeutics-to-attend-investor-conferences-in-march-302077149.html

SOURCE Calliditas Therapeutics

When will Renee Aguiar-Lucander, CEO of Calliditas, participate in the Carnegie Healthcare Seminar?

Renee Aguiar-Lucander will participate in the Carnegie Healthcare Seminar on Wednesday, March 6, 2024.

Which conference will Calliditas attend on March 13, 2024, in Miami, FL?

Calliditas will attend the Jefferies Biotech on the Bay Summit on March 13, 2024, in Miami, FL.

Who can be contacted for further information regarding Calliditas' conference participation?

For further information, contact Åsa Hillsten, Head of IR & Sustainability at Calliditas.

Where can the original content regarding Calliditas' conference participation be viewed?

The original content can be viewed at https://www.prnewswire.com/news-releases/calliditas-therapeutics-to-attend-investor-conferences-in-march-302077149.html.